Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Clinical Trials01:16

Clinical Trials

10.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.3K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Design Example: Setting a Curve Using Design Data01:09

Design Example: Setting a Curve Using Design Data

232
Designing and plotting a curve using field data requires precise calculations and execution. A horizontal curve with a radius of 200 meters and an intersection angle of 20 degrees is established using the method of perpendicular offsets from the long chord. The long chord, which spans between the curve's endpoints, is calculated to be 69.46 meters in length. To maintain accuracy in plotting, intervals of 3 meters are selected along the chord.The engineer determines the offset distances for each...
232
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

401
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
401
Group Design02:01

Group Design

10.4K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inference on summaries of a model-agnostic longitudinal variable importance trajectory with application to suicide prevention.

The annals of applied statistics·2026
Same author

Predicting and differentiating accidental and self-harm drug poisonings using health records data.

PLOS mental health·2026
Same author

Cost-Effectiveness of Remote Cognitive Behavioral Based Therapy for Chronic Pain among People with High-Impact Chronic Pain.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Substitution Patterns After Discontinuation of CNS-Active Medications in Older Adults in Primary Care.

Journal of the American Geriatrics Society·2026
Same author

Effect of self-management interventions on high impact chronic pain prevalence.

The journal of pain·2026
Same author

A pilot randomized controlled trial of an outreach intervention to improve depression treatment initiation among racial and ethnic groups.

General hospital psychiatry·2026

Related Experiment Video

Updated: Jan 27, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Improving pragmatic clinical trial design using real-world data.

Susan M Shortreed1,2, Carolyn M Rutter3, Andrea J Cook1,2

  • 11 Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.

Clinical Trials (London, England)
|March 15, 2019
PubMed
Summary
This summary is machine-generated.

Leverage historical electronic health record data to optimize pragmatic clinical trial design. This approach enhances sample size calculations and improves recruitment efficiency for suicide prevention studies.

Keywords:
Electronic medical recordsmental healthpower calculationspragmatic clinical trialsrandomized trial designsample size calculationsstudy designsuicide prevention

More Related Videos

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

3.1K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K

Related Experiment Videos

Last Updated: Jan 27, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

3.1K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K

Area of Science:

  • Clinical Trials
  • Health Informatics
  • Public Health

Background:

  • Pragmatic clinical trials increasingly utilize automated data sources like electronic health records (EHRs) for participant identification and outcome collection.
  • Automated data collection provides valuable insights during the trial design phase.
  • This study outlines methods for effectively using historical data to inform trial design decisions.

Purpose of the Study:

  • To demonstrate how historical EHR data can inform the design of pragmatic clinical trials.
  • To illustrate the application of these methods in a suicide-prevention trial.
  • To enhance the realism of power and sample size calculations.

Main Methods:

  • Utilized historical EHR data from 122,873 individuals with Patient Health Questionnaire (PHQ) responses.
  • Analyzed suicide attempt rates in the 18 months post-PHQ completion, focusing on PHQ item nine responses.
  • Conducted simulations using EHR data to estimate statistical power for detecting a 25% reduction in suicide attempts.

Main Results:

  • Suicide attempt rates varied based on PHQ item nine responses.
  • Estimated a decrease in individuals with elevated PHQ scores (history of suicidal ideation) from 50% to 5% over 50 weeks.
  • Simulation indicated 90% power to detect a 25% suicide attempt reduction with 8000 participants per arm (alpha=0.05).

Conclusions:

  • Historical data is crucial for informing pragmatic clinical trial design, especially those using automated data collection.
  • Real-world data enables more accurate sample size calculations and power estimations.
  • Data-informed trial design optimizes recruitment efficiency and statistical power.